• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 57,210.45
    454.45 (+0.80%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,489.95(%)
  • One 97
    1,090.00 1,090.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 765.00(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 205.60(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 208.95(%)
  • Monika Alcobev
    289.95 289.95(%)
  • St Bk of India
    825.00 889.00(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biofil Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Systematix
  • BSE Code : 3284.0
  • ISIN : INE829A01014
46.83 1 (1.92%)
  • As on 23 Jul 2025 (EOD)

  • Today’s Low

    44.50

  • Today’s High

    47.48

  • Open

    46.10

  • Perv Close

    45.95

  • 52W Low

    40.40

  • 52W High

    91.87

Key Indicators

  • P/E(TTM)

    138.21

  • Mar.Cap (₹Cr.)

    76.19

  • Div & Yield %

    0.00

  • Book Value(₹)

    11.54

  • Debt-Equity Ratio

    1.92

  • AGM Date

    23-Jul-2025

  • EPS

    0.34

  • P/E Ratio

    138.21

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    76.19

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.27

  • BV (₹)

    11.50

  • Sales( ₹ in Cr.)

    33.40

  • NP (in Cr.)

    0.56

  • NP Var(%)

    -21.0

  • Div%

    0.0

  • CPS (₹)

    0.60

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    76.45

  • 52 Week High

    91.87

  • 52 Week Low

    40.40

  • Price BSE

    47.0

  • Price NSE

    47.00

  • Market Capital( in Cr.)

    76.45

  • P/C Ratio

    81.60

  • P/E Ratio

    137.10

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 40.04 30.04 22.38 35.75 29.69 23.13
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 40.04 30.04 22.38 35.75 29.69 23.13
Other Income 0.49 0.10 0.15 0.80 0.17 0.10
Stock Adjustments 0.27 0.20 -3.59 2.77 0.34 -0.17
Total Income 40.80 30.34 18.94 39.32 30.20 23.06
EXPENDITURE :            
Raw Materials 37.78 27.62 15.87 35.20 25.65 19.82
Power and Fuel Cost 0.38 0.33 0.30 0.29 0.49 0.37
Employee Cost 0.50 0.45 0.79 0.75 0.86 0.89
Other Manufacturing Expenses 0.17 0.05 0.09 0.23 0.40 0.11
Selling and Administration Expenses 0.56 0.54 0.37 0.37 0.78 0.72
Miscellaneous Expenses 0.11 0.08 0.05 0.08 0.03 0.02
Employee Benefit Expenses 0.50 0.45 0.79 0.75 0.86 0.89
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 39.49 29.06 17.46 36.92 28.21 21.93
Operating Profit 1.30 1.26 1.48 2.40 1.99 1.12
Interest 0.04 0.04 0.04 0.07 0.12 0.16
Gross Profit 1.26 1.22 1.44 2.33 1.87 0.96
Depreciation 0.40 0.43 0.43 0.41 0.41 0.37
Profit Before Tax 0.86 0.79 1.01 1.92 1.46 0.59
Current Tax 0.24 0.22 0.28 0.32 0.26 0.12
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.09 0.01 0.04 0.35 0.00 0.00
Reported Net Profit 0.71 0.56 0.70 1.24 1.21 0.48
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.71 0.56 0.70 1.24 1.21 0.48
Adjustment below Net Profit 0.19 -0.10 0.04 0.00 0.03 0.00
P & L Balance brought forward -32.60 -33.06 -33.79 -35.01 -36.25 -36.73
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -31.69 -32.60 -33.06 -33.77 -35.01 -36.25
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.44 0.34 0.43 0.76 0.74 0.30
Earnings Per Share(Adj)-Unit Curr 0.44 0.34 0.43 0.76 0.74 0.30
Book Value 11.19 10.63 10.35 9.91 9.15 8.39
Book Value(Adj)-Unit Curr 11.19 10.63 10.35 9.91 9.15 8.39

Shareholding Pattern

  • Promoter Group

    46.82%

  • Public Share Holding

    53.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,314,200 26.51 4,314,200 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,304,560 20.31 3,304,560 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,618,760 46.82 7,618,760 15
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,200 0.04 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 135 0.00 135 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,000 0.04 0 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,335 0.08 135 5
2] Non Institution
Bodies Corporate 2,017,087 12.39 1,920,387 84
Clearing Members 3,586 0.02 3,586 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 65,800 0.40 0 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 205,468 1.26 122,768 292
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 136,513 0.84 136,513 172
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 632,298 3.89 632,298 11
Individuals holding nominal share capital up to Rs. 1 lakh 5,580,853 34.29 4,986,153 25,098
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 0 1
Others 0 0.00 0 0
Sub Total 8,641,705 53.10 7,801,705 25,665
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,273,800 100.00 15,420,600 25,685

Company Background

Biofil Chemicals & Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Biofil Chemicals & Pharmaceuticals Ltd
  • BSE Code : 3284.0
  • ISIN : INE829A01014

  • Incorporation Year

    1985

  • Registered Office

    11/12 Sector E Sanwer Road
    Sanwer Road Industrial Area, Indore,
    Madhya Pradesh-452015

  • Telephone

    91-731-2426700

  • FAX

    91-731-2420926

  • Chairman

    Ramesh Shah

  • Managing Director

    Ramesh Shah

  • Company Secretary

  • Auditor

    Maheshwari & Gupta

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Biofil Chemicals & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biofil Chemicals 46.99 40.53 40.04 138.21 1.81
Abbott India 34,745.50 6,684.73 6,409.15 52.20 44.95
Astrazeneca Phar 8,953.35 1,330.33 1,295.53 193.38 33.26
P & G Health Ltd 5,920.55 1,166.89 1,151.26 39.13 39.76
Glaxosmi. Pharma 3,130.55 3,866.05 3,723.49 57.71 58.72
Cipla 1,473.35 20,029.57 19,044.85 23.08 21.40
Amrutanjan Healt 692.60 437.58 421.23 39.40 20.84
Fermenta Biotec. 379.25 442.21 430.53 16.51 17.61
Guj. Themis Bio. 372.55 174.19 169.82 83.16 44.82
Bliss GVS Pharma 156.90 703.42 667.20 23.99 9.16
Ambalal Sarabhai 34.60 19.33 4.04 32.04 2.10